Artivion (AORT) director receives 7,576-share equity RSA grant

Rhea-AI Filing Summary

BEVEVINO DANIEL J reported acquisition or exercise transactions in this Form 4 filing.

ARTIVION, INC. director Daniel J. Bevevino reported receiving a grant of 7,576 shares of common stock as equity compensation. The award carried a price of $0.00 per share and increased his directly held position to 157,637 shares after the transaction. According to the footnote, this RSA grant will vest on May 18, 2027 under the company’s Equity and Cash Incentive Plan.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BEVEVINO DANIEL J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,576	$0.00	--

Holdings After Transaction: Common Stock — 157,637 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Equity grant size: 7,576 shares Grant price: $0.00 per share Holdings after grant: 157,637 shares +1 more

4 metrics

Equity grant size 7,576 shares Common Stock award to director Daniel J. Bevevino

Grant price $0.00 per share Stated transaction price for RSA grant

Holdings after grant 157,637 shares Total common shares directly held after transaction

Vesting date May 18, 2027 RSA grant vests under Equity and Cash Incentive Plan

Key Terms

RSA Grant, Equity and Cash Incentive Plan, grant/award acquisition, Form 4

4 terms

RSA Grant financial

"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan."

Equity and Cash Incentive Plan financial

"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan."

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BEVEVINO DANIEL J

(Last) (First) (Middle)

ARTIVION INC

1655 ROBERTS BLVD NW

(Street)

KENNESAW GEORGIA 30144

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/18/2026		A		7,576(1)	A	$0	157,637	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

Remarks:

	/s/ Daniel J. Bevevino	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ARTIVION (AORT) report for Daniel J. Bevevino?

ARTIVION reported that director Daniel J. Bevevino received a grant of 7,576 shares of common stock. The shares were acquired at a stated price of $0.00 per share as an equity award, not through an open-market purchase or sale.

How many ARTIVION (AORT) shares does Daniel J. Bevevino hold after this grant?

Following the reported equity grant, Daniel J. Bevevino directly holds 157,637 shares of ARTIVION common stock. This total includes the newly awarded 7,576 shares and reflects his direct ownership position disclosed in the Form 4 filing after the transaction.

What is the vesting schedule for Daniel J. Bevevino’s new ARTIVION (AORT) RSA grant?

The RSA grant to Daniel J. Bevevino is scheduled to vest on May 18, 2027. The footnote explains that this vesting occurs pursuant to the terms of ARTIVION’s Equity and Cash Incentive Plan governing restricted stock awards and similar equity incentives.

Was cash paid for the 7,576 ARTIVION (AORT) shares granted to Daniel J. Bevevino?

No cash was paid for these shares; the transaction price is listed as $0.00 per share. This indicates the 7,576 shares were granted as an equity award, consistent with compensation under the company’s Equity and Cash Incentive Plan, rather than bought in the market.

Does the Form 4 for ARTIVION (AORT) show any insider sales by Daniel J. Bevevino?

The Form 4 shows only an acquisition via a grant/award of 7,576 shares and no reported sales. Transaction data classify the code as a grant or award acquisition, and the summary counts no sell or disposition transactions in this filing.